Methylation of the RASSF1A, RARβ2, and SEMA3B genes in epithelial breast and ovarian tumors, and in patients with polyneoplasia

The methylation status of the tumor suppressor genes RASSF1A, RARβ2, and SEMA3B was studied in the samples of cancer and its histologically normal tissue of the breast and ovaries. The high rate of abnormal methylation of the CpG islet in the RASSF1A, RARβ2, and SEMA3B genes was found in the tumors...

Full description

Saved in:
Bibliographic Details
Main Authors: T. P. Kazubskaya, V. I. Loginov, D. S. Khodyrev, V. D. Ermilova, Yu. G. Payanidi, N. V. Chkhikvadze, V. Yu. Selchuk, E. A. Braga
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Опухоли женской репродуктивной системы
Subjects:
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/81
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849399080465203200
author T. P. Kazubskaya
V. I. Loginov
D. S. Khodyrev
V. D. Ermilova
Yu. G. Payanidi
N. V. Chkhikvadze
V. Yu. Selchuk
E. A. Braga
author_facet T. P. Kazubskaya
V. I. Loginov
D. S. Khodyrev
V. D. Ermilova
Yu. G. Payanidi
N. V. Chkhikvadze
V. Yu. Selchuk
E. A. Braga
author_sort T. P. Kazubskaya
collection DOAJ
description The methylation status of the tumor suppressor genes RASSF1A, RARβ2, and SEMA3B was studied in the samples of cancer and its histologically normal tissue of the breast and ovaries. The high rate of abnormal methylation of the CpG islet in the RASSF1A, RARβ2, and SEMA3B genes was found in the tumors of the breast (78% (32/41), 46% (26/56), and 35% (22/65), respectively) and ovaries 73% (33/45), 30% (15/50), and 50% (25/51). Hypermethylation in the CpG islets belonging to the RASSF1A and RARβ2 genes was first ascertained in 90% of the patients with polyneoplasms involving the breast and ovaries. Abnormal methylation of the promotor region of the RASSF1A gene was shown to be detectable in preclinical-stage and anaplasia-degree breast and ovarian cancer. There was a correlation of the rate of methylation in the promoter regions of the RARβ2 and SEMA3B genes with clinical-stage and anaplasia-degree breast and ovarian cancer. Analysis of gene methylation in biological fluids provides considerable opportunity to use methylation of DNA as a marker in clinical practice.
format Article
id doaj-art-43eb52fcc502467487c6a012e9234ce8
institution Kabale University
issn 1994-4098
1999-8627
language Russian
publishDate 2014-07-01
publisher ABV-press
record_format Article
series Опухоли женской репродуктивной системы
spelling doaj-art-43eb52fcc502467487c6a012e9234ce82025-08-20T03:38:25ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272014-07-0101616810.17650/1994-4098-2012-0-1-61-6896Methylation of the RASSF1A, RARβ2, and SEMA3B genes in epithelial breast and ovarian tumors, and in patients with polyneoplasiaT. P. Kazubskaya0V. I. Loginov1D. S. Khodyrev2V. D. Ermilova3Yu. G. Payanidi4N. V. Chkhikvadze5V. Yu. Selchuk6E. A. Braga7N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical SciencesState Research Center, State Research Institute of Genetics, MoscowState Research Center, State Research Institute of Genetics, MoscowN.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical SciencesN.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical SciencesN.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical SciencesN.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical SciencesState Research Center, State Research Institute of Genetics, MoscowThe methylation status of the tumor suppressor genes RASSF1A, RARβ2, and SEMA3B was studied in the samples of cancer and its histologically normal tissue of the breast and ovaries. The high rate of abnormal methylation of the CpG islet in the RASSF1A, RARβ2, and SEMA3B genes was found in the tumors of the breast (78% (32/41), 46% (26/56), and 35% (22/65), respectively) and ovaries 73% (33/45), 30% (15/50), and 50% (25/51). Hypermethylation in the CpG islets belonging to the RASSF1A and RARβ2 genes was first ascertained in 90% of the patients with polyneoplasms involving the breast and ovaries. Abnormal methylation of the promotor region of the RASSF1A gene was shown to be detectable in preclinical-stage and anaplasia-degree breast and ovarian cancer. There was a correlation of the rate of methylation in the promoter regions of the RARβ2 and SEMA3B genes with clinical-stage and anaplasia-degree breast and ovarian cancer. Analysis of gene methylation in biological fluids provides considerable opportunity to use methylation of DNA as a marker in clinical practice.https://ojrs.abvpress.ru/ojrs/article/view/81breast cancerovarian cancerpolyneoplasiamethylationrassf1ararβ2and sema3b genes
spellingShingle T. P. Kazubskaya
V. I. Loginov
D. S. Khodyrev
V. D. Ermilova
Yu. G. Payanidi
N. V. Chkhikvadze
V. Yu. Selchuk
E. A. Braga
Methylation of the RASSF1A, RARβ2, and SEMA3B genes in epithelial breast and ovarian tumors, and in patients with polyneoplasia
Опухоли женской репродуктивной системы
breast cancer
ovarian cancer
polyneoplasia
methylation
rassf1a
rarβ2
and sema3b genes
title Methylation of the RASSF1A, RARβ2, and SEMA3B genes in epithelial breast and ovarian tumors, and in patients with polyneoplasia
title_full Methylation of the RASSF1A, RARβ2, and SEMA3B genes in epithelial breast and ovarian tumors, and in patients with polyneoplasia
title_fullStr Methylation of the RASSF1A, RARβ2, and SEMA3B genes in epithelial breast and ovarian tumors, and in patients with polyneoplasia
title_full_unstemmed Methylation of the RASSF1A, RARβ2, and SEMA3B genes in epithelial breast and ovarian tumors, and in patients with polyneoplasia
title_short Methylation of the RASSF1A, RARβ2, and SEMA3B genes in epithelial breast and ovarian tumors, and in patients with polyneoplasia
title_sort methylation of the rassf1a rarβ2 and sema3b genes in epithelial breast and ovarian tumors and in patients with polyneoplasia
topic breast cancer
ovarian cancer
polyneoplasia
methylation
rassf1a
rarβ2
and sema3b genes
url https://ojrs.abvpress.ru/ojrs/article/view/81
work_keys_str_mv AT tpkazubskaya methylationoftherassf1ararb2andsema3bgenesinepithelialbreastandovariantumorsandinpatientswithpolyneoplasia
AT viloginov methylationoftherassf1ararb2andsema3bgenesinepithelialbreastandovariantumorsandinpatientswithpolyneoplasia
AT dskhodyrev methylationoftherassf1ararb2andsema3bgenesinepithelialbreastandovariantumorsandinpatientswithpolyneoplasia
AT vdermilova methylationoftherassf1ararb2andsema3bgenesinepithelialbreastandovariantumorsandinpatientswithpolyneoplasia
AT yugpayanidi methylationoftherassf1ararb2andsema3bgenesinepithelialbreastandovariantumorsandinpatientswithpolyneoplasia
AT nvchkhikvadze methylationoftherassf1ararb2andsema3bgenesinepithelialbreastandovariantumorsandinpatientswithpolyneoplasia
AT vyuselchuk methylationoftherassf1ararb2andsema3bgenesinepithelialbreastandovariantumorsandinpatientswithpolyneoplasia
AT eabraga methylationoftherassf1ararb2andsema3bgenesinepithelialbreastandovariantumorsandinpatientswithpolyneoplasia